These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34558151)

  • 1. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.
    Salazar-Mendiguchía J; Barriales-Villa R; Lopes LR; Ochoa JP; Rodríguez-Vilela A; Palomino-Doza J; Larrañaga-Moreira JM; Cicerchia M; Cárdenas-Reyes I; García-Giustiniani D; Brögger N; Fernández G; García S; Santiago L; Vélez P; Ortiz-Genga M; Elliott PM; Monserrat L
    Eur J Med Genet; 2020 Dec; 63(12):104079. PubMed ID: 33035702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Muscle LIM Protein C58G causes cardiomyopathy through protein depletion.
    Ehsan M; Kelly M; Hooper C; Yavari A; Beglov J; Bellahcene M; Ghataorhe K; Poloni G; Goel A; Kyriakou T; Fleischanderl K; Ehler E; Makeyev E; Lange S; Ashrafian H; Redwood C; Davies B; Watkins H; Gehmlich K
    J Mol Cell Cardiol; 2018 Aug; 121():287-296. PubMed ID: 30048712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
    Geier C; Gehmlich K; Ehler E; Hassfeld S; Perrot A; Hayess K; Cardim N; Wenzel K; Erdmann B; Krackhardt F; Posch MG; Osterziel KJ; Bublak A; Nägele H; Scheffold T; Dietz R; Chien KR; Spuler S; Fürst DO; Nürnberg P; Ozcelik C
    Hum Mol Genet; 2008 Sep; 17(18):2753-65. PubMed ID: 18505755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish patients with hypertrophic cardiomyopathy.
    Lipari M; Wypasek E; Karpiński M; Tomkiewicz-Pajak L; Laino L; Binni F; Giannarelli D; Rubiś P; Petkow-Dimitrow P; Undas A; Grammatico P; Bottillo I
    Pol Arch Intern Med; 2020 Feb; 130(2):89-99. PubMed ID: 31919335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene.
    Hartmannova H; Kubanek M; Sramko M; Piherova L; Noskova L; Hodanova K; Stranecky V; Pristoupilova A; Sovova J; Marek T; Maluskova J; Ridzon P; Kautzner J; Hulkova H; Kmoch S
    Circ Cardiovasc Genet; 2013 Dec; 6(6):543-51. PubMed ID: 24114807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.
    Huang S; Pu T; Wei W; Xu R; Wu Y
    J Gene Med; 2020 Mar; 22(3):e3146. PubMed ID: 31742804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIM domain-wide comprehensive virtual mutagenesis provides structural rationale for cardiomyopathy mutations in CSRP3.
    Chauhan PK; Sowdhamini R
    Sci Rep; 2022 Mar; 12(1):3562. PubMed ID: 35241752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
    Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
    Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy.
    Newman B; Cescon D; Woo A; Rakowski H; Erikkson MJ; Sole M; Wigle ED; Siminovitch KA
    Mol Genet Metab; 2005 Apr; 84(4):374-5. PubMed ID: 15781201
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel gene-trap line reveals the dynamic patterns and essential roles of cysteine and glycine-rich protein 3 in zebrafish heart development and regeneration.
    Liang S; Zhou Y; Chang Y; Li J; Zhang M; Gao P; Li Q; Yu H; Kawakami K; Ma J; Zhang R
    Cell Mol Life Sci; 2024 Mar; 81(1):158. PubMed ID: 38556571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.
    Geier C; Perrot A; Ozcelik C; Binner P; Counsell D; Hoffmann K; Pilz B; Martiniak Y; Gehmlich K; van der Ven PF; Fürst DO; Vornwald A; von Hodenberg E; Nürnberg P; Scheffold T; Dietz R; Osterziel KJ
    Circulation; 2003 Mar; 107(10):1390-5. PubMed ID: 12642359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death.
    Azimi A; Soveizi M; Salmanipour A; Mozafarybazargany M; Ghaffari Jolfayi A; Maleki M; Kalayinia S
    ESC Heart Fail; 2024 Oct; 11(5):3180-3190. PubMed ID: 38874371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel
    Tong W; Liu W; Guo H; Wang J; Yu S; Zhang J; Liu C; Chen J; Zhao X
    Cardiol Young; 2020 Jan; 30(1):100-106. PubMed ID: 31747981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing reveals a likely pathogenic LMNA variant causing hypertrophic cardiomyopathy.
    Mahdavi M; Mohsen-Pour N; Maleki M; Ghasemi S; Tabib A; Houshmand G; Naderi N; Masoumi T; Pouraliakbar H; Kalayinia S
    Lab Med; 2024 Jan; 55(1):62-70. PubMed ID: 37246508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.